Verastem Oncology
VSTM
#7578
Rank
โ‚ฌ0.28 B
Marketcap
6,40ย โ‚ฌ
Share price
4.02%
Change (1 day)
-34.48%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2024 (TTM): -โ‚ฌ85.28 Million

According to Verastem Oncology 's latest financial reports the company's current earnings are โ‚ฌ10 Million. In 2023 the company made an earning of -โ‚ฌ80.1 Million a decrease over its 2022 earnings that were of -โ‚ฌ67.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ85.28 Million6.46%
2023 -โ‚ฌ80.1 Million18.36%
2022 -โ‚ฌ67.68 Million3.67%
2021 -โ‚ฌ65.28 Million5.43%
2020 -โ‚ฌ61.92 Million-54.74%
2019 -โ‚ฌ0.14 Billion105.99%
2018 -โ‚ฌ66.41 Million6.83%
2017 -โ‚ฌ62.17 Million86.06%
2016 -โ‚ฌ33.41 Million-37.03%
2015 -โ‚ฌ53.06 Million8.43%
2014 -โ‚ฌ48.93 Million29.52%
2013 -โ‚ฌ37.78 Million28.6%
2012 -โ‚ฌ29.38 Million133.9%
2011 -โ‚ฌ12.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ41.09 Million-52.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ10.18 B-11,991.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.07 B-1,349.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.02 B-4,802.36%๐Ÿ‡ฌ๐Ÿ‡ง UK